Driehaus Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-250,484
| Closed | -$1.85M | – | 390 |
|
|
2018
Q4 | $1.85M | Sell |
250,484
-252,512
| -50% | -$1.87M | 0.08% | 231 |
|
|
2018
Q3 | $7.3M | Sell |
502,996
-82,212
| -14% | -$1.19M | 0.22% | 140 |
|
|
2018
Q2 | $11.7M | Sell |
585,208
-5,968
| -1% | -$119K | 0.4% | 71 |
|
|
2018
Q1 | $10.4M | Buy |
591,176
+67,748
| +13% | +$1.19M | 0.37% | 63 |
|
|
2017
Q4 | $12.9M | Buy |
523,428
+222,254
| +74% | +$5.48M | 0.49% | 44 |
|
|
2017
Q3 | $7.77M | Buy |
301,174
+25,564
| +9% | +$660K | 0.3% | 84 |
|
|
2017
Q2 | $7.48M | Sell |
275,610
-55,587
| -17% | -$1.51M | 0.27% | 80 |
|
|
2017
Q1 | $9.88M | Sell |
331,197
-136,740
| -29% | -$4.08M | 0.34% | 66 |
|
|
2016
Q4 | $12.7M | Buy |
467,937
+285,002
| +156% | +$7.74M | 0.45% | 40 |
|
|
2016
Q3 | $4.69M | Buy |
+182,935
| New | +$4.69M | 0.16% | 134 |
|